Short Interest in Nukkleus Inc. (NASDAQ:DFNS) Rises By 108.6%

Nukkleus Inc. (NASDAQ:DFNS) saw a large growth in short interest in the month of August. As of August 31st, there was short interest totaling 301,468 shares, a growth of 108.6% from the August 15th total of 144,490 shares. Currently, 20.4% of the shares of the company are short sold. Based on an average daily volume of 1,811,869 shares, the short-interest ratio is presently 0.2 days.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Noble Financial raised Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. Wall Street Zen lowered Nukkleus from a “sell” rating to a “strong sell” rating in a report on Saturday, September 5th. Finally, Weiss Ratings cut Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Nukkleus has a consensus rating of “Moderate Buy”.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Millennium Management LLC acquired a new stake in Nukkleus during the 4th quarter worth $60,000. Engineers Gate Manager LP acquired a new position in Nukkleus during the fourth quarter worth $96,000. Price T Rowe Associates Inc. MD purchased a new stake in Nukkleus in the 4th quarter valued at $57,000. GM Advisory Group LLC purchased a new stake in Nukkleus in the 4th quarter valued at $56,000. Finally, State Street Corp increased its stake in shares of Nukkleus by 70.7% in the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after acquiring an additional 7,400 shares during the last quarter. Institutional investors and hedge funds own 12.47% of the company’s stock.

Nukkleus Price Performance

DFNS traded down $0.36 during trading on Monday, hitting $9.23. The company’s stock had a trading volume of 236,043 shares, compared to its average volume of 1,325,569. The firm has a market capitalization of $15.32 million, a price-to-earnings ratio of -0.02 and a beta of -5.88. Nukkleus has a twelve month low of $3.70 and a twelve month high of $1,948.75. The business’s fifty day simple moving average is $21.24 and its 200 day simple moving average is $62.83. The company has a current ratio of 0.14, a quick ratio of 0.11 and a debt-to-equity ratio of 0.07.

Nukkleus (NASDAQ:DFNS) last announced its earnings results on Wednesday, August 19th. The company reported ($173.80) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.11) by ($170.69). The firm had revenue of $4.00 million during the quarter, compared to analysts’ expectations of $4.50 million. On average, equities research analysts forecast that Nukkleus will post -3.9 EPS for the current fiscal year.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.